Oncofertility Journal Articles

abstract

• Abstract Adolescents and young adults aged 15 to 39 years who are diagnosed with cancer (AYA survivors) undergo a range of therapies for cancer cure but subsequently may be at risk of treatment-related infertility, and for female AYA survivors, adverse pregnancy outcomes. Future fertility is important to AYA survivors. Meeting their fertility goals requires awareness of this importance, knowledge of cancer treatment–related fertility risks, appropriate fertility counseling on these risks, and access to fertility care. Epidemiologic and dissemination and implementation research are needed to estimate more precise risks of traditional and novel cancer therapies on fertility and pregnancy outcomes and improve the delivery of fertility care.

authors

• Irene Su, H
• Lee, Yuton Tony
• Barr, Ronald Duncan

status

• published 

publication date

• November 2018

has subject area

• 1112 Oncology and Carcinogenesis (FoR)
• Adolescent (MeSH)
• Adult (MeSH)
• Age Factors (MeSH)
• Antineoplastic Agents (MeSH)
• Cancer Survivors (MeSH)
• Female (MeSH)
• Fertility (MeSH)
• Fertility Preservation (MeSH)
• Humans (MeSH)
• Male (MeSH)
• Medical Oncology (MeSH)
• Neoplasms (MeSH)
• Oncology & Carcinogenesis (Science Metrix)
• Ovary (MeSH)
• Practice Guidelines as Topic (MeSH)
• Pregnancy (MeSH)
• Pregnancy Outcome (MeSH)
• Spermatozoa (MeSH)
• Young Adult (MeSH)

published in

• Cancer Journal  Journal

keywords

• Adolescent
• Adult
• Age Factors
• Antineoplastic Agents
• Cancer Survivors
• Female
• Fertility
• Fertility Preservation
• Humans
• Male
• Medical Oncology
• Neoplasms
• Ovary
• Practice Guidelines as Topic
• Pregnancy
• Pregnancy Outcome
• Spermatozoa
• Young Adult

Digital Object Identifier (DOI)

• 10.1097/ppo.0000000000000344

start page

• 328

end page

• 335

volume

• 24

issue

• 6